Erratum to: High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor. [PDF]
europepmc +1 more source
Correction to: Erratum to: TRLS-11. PNOC005: ONCOLYTIC MEASLES VIRUS FOR THE TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT MEDULLOBLASTOMA OR ATYPICAL TERATOID RHABDOID TUMOR. [PDF]
europepmc +1 more source
Biomarkers of Treatment Response in Paediatric Medulloblastoma. [PDF]
Bayanova M +6 more
europepmc +1 more source
Significance of Early Proton Beam Therapy Initiation in Achieving Complete Response in Pediatric Medulloblastoma: A Retrospective Study. [PDF]
Shen Z +12 more
europepmc +1 more source
Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis. [PDF]
Yan Z, Ou Y, Han X, Gong J.
europepmc +1 more source
Subtype-specific prognostic impact of TNIK in medulloblastoma. [PDF]
Klaus FL +10 more
europepmc +1 more source
Recognising pituitary and thyroid dysfunction after craniospinal radiotherapy: an underrecognised mixed endocrine toxicity. [PDF]
Slabbynck K +4 more
europepmc +1 more source
Endocrine disorders in pediatric medulloblastoma survivors treated with X-ray or proton beam therapy: a single-institution retrospective study. [PDF]
Kaneko N +20 more
europepmc +1 more source
Comment on Santana-Bejarano et al. NRP1 and GFAP Expression in the Medulloblastoma Microenvironment: Implications for Angiogenesis and Tumor Progression. <i>Cancers</i> 2025, <i>17,</i> 2417. [PDF]
Roesler R, Isolan GR.
europepmc +1 more source

